āĻšā§āĻŽFRE âĸ ETR
add
Fresenius SE & Co KGaA
ā§Šā§Š.ā§Šā§§âŦ
ā§¨ā§¨ āĻ¨āĻā§, ā§Ž:ā§Šā§Ļ:ā§Ļā§Ļ PM GMT +ā§§ · EUR · ETR · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻ¸ā§āĻāĻDE-āĻ āĻ¤āĻžāĻ˛āĻŋāĻāĻžāĻā§āĻā§āĻ¤ āĻ¸āĻŋāĻāĻŋāĻāĻ°āĻŋāĻāĻŋDE-āĻ āĻšā§āĻĄāĻā§ā§āĻžāĻ°ā§āĻāĻžāĻ°
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§Šā§¨.ā§ā§¯âŦ
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§Šā§¨.ā§Ŧā§§âŦ - ā§Šā§Š.ā§Šā§âŦ
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§¨ā§Ē.ā§Šā§¨âŦ - ā§Šā§Ŧ.ā§¨ā§ĒâŦ
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§§ā§Ž.ā§Ŧā§ĒāĻļāĻ¤Â āĻā§ EUR
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§¯.ā§Žā§ŽÂ āĻ˛āĻž
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
-
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
-
āĻĒā§āĻ°āĻžāĻāĻŽāĻžāĻ°āĻŋ āĻāĻā§āĻ¸āĻā§āĻā§āĻ
ETR
āĻŦāĻžāĻāĻžāĻ° āĻ¸āĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
(EUR) | āĻ¸ā§āĻĒ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§Ģā§Šā§Ŧ.ā§Ŧā§Ļ āĻā§ | ā§Š.ā§Ēā§Ģ% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§Žā§.ā§§ā§Ļ āĻā§ | -ā§¨.ā§ā§¯% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§Šā§¨.ā§Ŧā§Ļ āĻā§ | ā§§ā§Žā§Ļ.ā§Šā§Ļ% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | ā§Ŧ.ā§Ļā§Ž | ā§§ā§ā§.ā§Ŧā§Ģ% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§Ļ.ā§Ŧā§¯ | ā§§ā§Š.ā§§ā§§% |
EBITDA | ā§ā§Ē.ā§ā§Ļ āĻā§ | ā§§ā§Ģ.ā§Ŧā§Š% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | ā§¨ā§Š.ā§§ā§Š% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(EUR) | āĻ¸ā§āĻĒ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§§ā§Ēā§¯.ā§Ēā§Ļ āĻā§ | ā§Šā§Ŧ.ā§Ēā§Ē% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§Ēā§¨.ā§Šā§āĻļāĻ¤Â āĻā§ | -ā§Ēā§Š.ā§ā§Ŧ% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§¨ā§¨.ā§¯ā§ŦāĻļāĻ¤Â āĻā§ | -ā§Ēā§¯.ā§Ļā§¨% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§§ā§¯.ā§Ēā§ĻāĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§Ģā§Ŧ.ā§Šā§¨Â āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§Ļ.ā§¯ā§Ž | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§¨.ā§Žā§Ŧ% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | ā§Š.ā§ā§Ē% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
(EUR) | āĻ¸ā§āĻĒ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§Šā§¨.ā§Ŧā§Ļ āĻā§ | ā§§ā§Žā§Ļ.ā§Šā§Ļ% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | ā§ā§.ā§¯ā§Ļ āĻā§ | -ā§Ēā§Ē.ā§Ŧā§% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§§ā§Ļ.ā§Žā§Ļ āĻā§ | ā§Žā§¨.ā§Ļā§¯% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§¨ā§¯.ā§Ŧā§Ļ āĻā§ | ā§Ģā§¨.ā§¯ā§Ē% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | ā§Šā§Ž.ā§Ŧā§Ļ āĻā§ | ā§§ā§¨ā§Ž.ā§Ļā§Ģ% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | ā§Ģā§Ŧ.ā§§ā§Ļ āĻā§ | ā§§ā§Ļā§Ģ.ā§§ā§Ģ% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
Fresenius SE & Co. KGaA is a European multinational health care company based in Bad Homburg vor der HÃļhe, Germany. It provides products and services for dialysis in hospitals, as well as inpatient and outpatient medical care. The company is involved in hospital management and in engineering and services for medical centers and other health care facilities.
The company is ranked 411th in the Forbes Global 2000 list in 2023.
In March 2022, it announced plans to merge with InterWell Health and Cricket Health to form a new company, which will operate under the InterWell Health brand, focused on services for the earlier stages of kidney disease. Wikipedia
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§§ā§¯ā§§ā§¨
āĻ¸āĻĻāĻ° āĻĻāĻĒā§āĻ¤āĻ°
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§§,ā§ā§,ā§Ļā§¯ā§§